The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea

International Journal of Obesity

Volumn 31, Issue 1, 2007, Pages 161-168

  Yee, B J ^a,b   Phillips, C L ^a,d   Banerjee, D ^a   Caterson, I ^a   Hedner, J A ^a,b,c   Grunstein, R R ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Heart rate; Hypertension; Obstructive sleep apnoea; Weight loss

Indexed keywords

SIBUTRAMINE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG WITHDRAWAL; EPWORTH SLEEPINESS SCALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK; OBESITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SIDE EFFECT; SINUS TACHYCARDIA; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; APPETITE DEPRESSANTS; BLOOD PRESSURE; COHORT STUDIES; CYCLOBUTANES; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYSOMNOGRAPHY; RESPIRATION DISORDERS; SLEEP APNEA, OBSTRUCTIVE; WEIGHT LOSS;

EID: 33845734723     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803363     Document Type: Article

References (44)

1. Malhotra A, White DP. Obstructive sleep apnoea. Lancet 2002; 360: 237-245.
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
3. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
4. Bearpark H, Elliott L, Grunstein R, Cullen S, Schneider H, Althaus W et al. Snoring and sleep apnea. A population study in Australian men. Am J Respir Crit Care Med 1995; 151: 1459-1465.
5. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993; 17: 533-540.
6. Grunstein RR, Stenlof K, Hedner JA, Sjostrom L. Impact of self-reported sleep-breathing disturbances on psychosocial performance in the Swedish Obese Subjects (SOS) Study. Sleep 1995; 18: 635-643.
7. Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003; 168: 522-530.
8. Jordan AS, White DP, Fogel RB. Recent advances in understanding the pathogenesis of obstructive sleep apnea. Curr Opin Pulm Med 2003; 9: 459-464.
9. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
10. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003; 108: 9-12.
11. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000; 18: 679-685.
12. Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003; 124: 594-601.
13. Gordon P, Sanders MH. Positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax 2005; 60: 68-75.
14. Barvaux VA, Aubert G, Rodenstein DO. Weight loss as a treatment for obstructive sleep apnoea. Sleep Med Rev 2000; 4: 435-452.
15. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 1996; 19: 104-115.
16. Klein S. Long-term pharmacotherapy for obesity. Obes Res 2004; 12: 163S-1166.
17. Kamel EG, McNeill G, Van Wijk MC. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes Relat Metab Disord 2000; 24: 607-613.
18. Martinez D, Basile BR. Sibutramine does not worsen sleep apnea syndrome: a randomized double-blind placebo-controlled study. Sleep Med 2005; 6: 467-470.
19. Stevens VJ, Obarzanek E, Cook NR, Lee I-M, Appel LJ, Smith West D et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med 2001; 134: 1-11.
20. Kim SH, Lee YM, Jee SH, Nam CM. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Obes Res 2003; 11: 1116-1123.
21. Jordan J, Scholze J, Matiba B, Wirth A, Hauner H, Sharma AM. Influence of sibutramine on blood pressure: evidence from placebo-controlled trials. Int J Obes Relat Metab Disord 2005; 29: 509-516.
22. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al., for the Sleep Heart Health Study. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829-1836.
23. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004; 79: 1036-1046.
24. James WPT, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000; 356: 2119-2125.
25. Lohmann T, Roche A, Martello R. Anthrometrics standardization reference manual. Hum Kinet 1988.
26. Rechtschaffen A. A manual of standardized terminology, technique and scoring system for sleep stages of human subjects. Brain Inform Services/Brain Res Inst 1968.
27. Anonymous. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. [see comment]. Sleep 1999; 22: 667-689.
28. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
29. Smith IE, Quinnell TG. Pharmacotherapies for obstructive sleep apnoea: where are we now? Drugs 2004; 64: 1385-1399.
30. Wesnes KA, Garratt C, Wickens M, Gudgeon A, Oliver S. Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers. Br J Clin Pharmacol 2000; 49: 110-117.
31. McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2000; 160: 2185-2191.
32. Grote L, Hedner J, Peter JH. Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens 2001; 19: 683-690.
33. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-210.
34. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
35. Birkenfeld AL, Schroeder C, Boschmann M, Tank J, Franke G, Luft FC et al. Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation 2002; 106: 2459-2465.
36. Birkenfeld AL, Schroeder C, Pischon T, Tank J, Luft FC, Sharma AM et al. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients. Clin Autonom Res 2005; 15: 200-206.
37. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuatingmuscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 1988; 6: S529-31.
38. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a french population : role of age, gender, and blood pressure. Hypertension 1999; 33: 44-52.
39. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-247.
40. Grunstein R. Continuous positive airway pressure for obstructive sleep apnea-hypopnea. In: Kryger RaD (ed). Principles and Practice of Sleep Medicine. Elsevier Saunders: Philadelphia, 2005. pp 1066-1080.
41. Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 656-664.
42. Pepin JL, Veale D, Mayer P, Bettega G, Wuyam B, Levy P. Critical analysis of the results of surgery in the treatment of snoring, upper airway resistance syndrome (UARS), and obstructive sleep apnea (OSA). Sleep 1996; 19: S90-S100.
43. Filippatos TD, Kiortsis DN, Liberopoulos EN, Mikhailidis DP, Elisaf MS. A review of the metabolic effects of sibutramine. Curr Med Res Opin 2005; 21: 457-468.
44. Douglas NJ, Engleman HM, Faccenda JF, McArdle N. The science of designing ethical CPAP trials. Am J Respir Crit Care Med 2002; 165: 132a-1134.